Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
11/2005
11/09/2005CN1694870A Acetyl 2-hydroxy-1, 3-diaminoalkanes
11/09/2005CN1226294C Fused heteroaromatic glucokinase activators
11/09/2005CN1226291C Preparing method for 1H-quinoline-2-ketone compound
11/09/2005CN1226250C Anthracene derivatives and organic electroluminescent device made by using the same
11/08/2005US6962931 Oral bioavailability of a CETP inhibitor
11/08/2005US6962930 such as N,N-diphenyl)-4-ureido-5,7-dichloro-2-carboxyquinolinefor treatment of drug abuse/dependence; side effects reduction
11/08/2005US6962928 such as 6-methoxy-2-(4-methoxyphenyl)-1-[4-(2-piperidin-1-yl-ethyoxy)-phenyl]-1,2,3,4-tetrahydroquinoline
11/08/2005CA2247020C Possibly substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives
11/08/2005CA2155104C Heterocyclic-substituted alkyl amide acat inhibitors
11/03/2005WO2005103683A1 Quantitative method of determining beryllium or a compound thereof in a sample
11/03/2005WO2005103030A1 1,4-di substituted benzene compounds, process for preparing the same and use thereof
11/03/2005WO2005103018A1 Urea derivatives as antagonists of the vanilloid receptor (vr1)
11/03/2005WO2005103007A1 Crystalline 6-ethoxy-2,2,4-trimethyl-tetrahydroquinoline and a method for the production thereof
11/03/2005WO2005102980A1 Novel compounds, the preparation and the use thereof for a regiospesific synthesis of perfluor(alkyl) group heterocycles
11/03/2005WO2005070890A3 Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof
11/03/2005US20050245747 e.g. 2-[2-(5-chloro-benzo[b]thiophen-2-yl)-phenylmethanesulfinyl]-acetamide; autoimmune disorders, antidepressant; narcolepsy, Parkinson's, Alzheimer's disease; attention deficit hyperactivity disorder; sleep disorder, fatigue
11/03/2005US20050245570 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
11/03/2005US20050245569 decyclization of {3-[(E)-2(7-chloro-2-quinolinyl)vinyl]phenyl}-4,5-dihydro-3H-benzo[c]thiepin-1-one by methylmagnesium halide with following conversion to montelukast
11/03/2005US20050245568 decyclization of {3-[(E)-2(7-chloro-2-quinolinyl)vinyl]phenyl}-4,5-dihydro-3H-benzo[c]thiepin-1-one by methylmagnesium halide with following conversion to montelukast
11/03/2005US20050245525 Compounds useful for inhibiting CHK1
11/03/2005US20050245523 Heteroaryl derivatives and their use as medicaments
11/03/2005US20050245513 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
11/03/2005US20050245505 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as antibacterial agents
11/03/2005US20050244349 Methods for stabilizing ingredients within cosmetics, personal care and household products
11/03/2005CA2563494A1 Urea derivatives as antagonists of the vanilloid receptor (vr1)
11/02/2005EP1591099A2 Methods for stabilizing ingredients within cosmetics, personal care and household products
11/02/2005EP1590328A2 (2-carboxamido) (3-amino) thiophene compounds
11/02/2005EP1590321A2 Aryl alkyl carbamate derivatives production and use thereof in therapy
11/02/2005EP1590319A1 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
11/02/2005EP1480953B1 Process for preparing aripiprazole
11/02/2005EP1263503B1 Use of cyanoquinolines for treating or inhibiting colonic polyps
11/02/2005EP0990648B1 4-quinolinol derivatives and agrohorticultural bactericides containing the same as active ingredient
11/02/2005CN1692101A 4-oxoquinoline compounds and utilization thereof as HIV integrase inhibitors
11/02/2005CN1225465C Novel compounds
11/01/2005US6960580 Kinase inhbitor; antiproliferative agents
10/2005
10/27/2005WO2005100321A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases
10/27/2005WO2005100320A2 Crystalline 2-amino-3-cyanoquinoline derivatives, process of their preparation and pharmaceutical compositions containing them
10/27/2005WO2005100308A1 Thio-substituted biaryl-methanesulfinyl derivatives
10/27/2005WO2005100298A1 Cetp inhibitors
10/27/2005WO2005099688A2 Cyclic compounds
10/27/2005WO2005066115A8 Disubstituted chalcone oximes having rarϝ retinoid receptor antagonist activity
10/27/2005WO2004089366A8 Bicyclic compounds as nr2b receptor antagonists
10/27/2005US20050240023 Cathepsin cysteine protease inhibitors
10/27/2005US20050239819 4-Oxoquinoline compounds and utilization thereof as hiv integrase inhibitors
10/27/2005US20050239791 Substituted 1-heteroaryl-4-substituted piperazine and piperidine analogues
10/27/2005US20050239684 Compounds which inhibit beta-secretase activity and methods of use thereof
10/27/2005CA2569007A1 Crystalline 2-amino-3-cyanoquinoline derivatives, process of their preparation and pharmaceutical compositions containing them
10/27/2005CA2562244A1 Cyclic compounds
10/27/2005CA2562082A1 Cetp inhibitors for the treatment and prevention of atherosclerosis
10/27/2005CA2561564A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases
10/26/2005EP1587804A1 Androgen receptor antagonists
10/26/2005EP1587509A2 Androgen receptor antagonists
10/26/2005EP1587473A2 Thiosemicarbazones as anti-virals and immunopotentiators
10/26/2005EP1492535B1 Anhydrous crystalline forms i and ii of 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl) 4-oxo-1, 4-dihydroquinoline-3-carboxylic acid (gatifloxacin)
10/26/2005EP1427408A4 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-$g(a) CONVERTING ENZYME (TACE)
10/26/2005EP1183229B1 Glucagon antagonists/inverse agonists
10/26/2005EP1131312B1 Novel pyrimidine derivatives and processes for the preparation thereof
10/26/2005EP1129071B1 Phenyl-substituted cyclic enaminones
10/26/2005CN1688549A Compound having TGF-beta inhibitory activity and medicinal composition containing the same
10/26/2005CN1688547A A-'7-halo-2-quino (xa-) linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents
10/26/2005CN1688545A Phosphodiesterase 4 inhibitors, including n-substituted phenylamine and diphenylamine analogs
10/26/2005CN1687035A Derivative of 8-hydroxyquinoline of emitting red light
10/26/2005CN1224598C Naphthalene derivatives
10/25/2005US6958346 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein
10/20/2005WO2005097752A1 Quinolone carboxylic acid derivatives for treatment of hyperproliferative conditions
10/20/2005WO2005097747A1 Histone deacetylase inhibitor prodrugs
10/20/2005WO2005097746A2 2-propene-1-ones as hsp 70 inducers
10/20/2005WO2005097137A2 Advanced quinazoline based protein kinase inhibitors
10/20/2005WO2005097134A2 Quinazoline based protein kinase inhibitors
10/20/2005WO2005070891A3 Compounds and methods of use
10/20/2005WO2005066129A3 Bis-pyridino containing compounds for use in the treatment of cns pathologies
10/20/2005WO2005066116A8 Disubstituted chalcone oximes as selective agonists of rarϝ retinoid receptors
10/20/2005US20050234241 Process for the preparation of [R-(E)-1-[[[1-[3-[2-[7-chloro-2-quinolinyl]ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid (montelukast) and its pharmaceutically acceptable salts
10/20/2005US20050234238 8-(Biaryl)quinoline pde4 inhibitors
10/20/2005US20050234125 Alpha-sulfonylamino-acetonitriles
10/20/2005US20050234109 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine
10/20/2005US20050234099 Microsomal triglyceride transfer protein (MTP) inhibitor (S)-2-[(4'-Isopropoxybiphenyl-2-carbonyl)amino]quinoline-6-carboxylic acid {[(4-fluoro-benzyl)methylcarbamoyl]phenylmethyl}amide; treating obesity
10/20/2005US20050234071 Aripiprazole crystalline forms
10/20/2005US20050234061 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/20/2005US20050234058 Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
10/20/2005US20050234044 Cyclic amine derivatives and methods of use
10/20/2005CA2561621A1 Quinolone carboxylic acid derivatives for treatment of hyperproliferative conditions
10/20/2005CA2561617A1 Histone deacetylase inhibitor prodrugs
10/19/2005EP1586578A2 Method of removing allyl series protecting group using novel ruthenium complex and method of synthesizing allyl ethers
10/19/2005EP1586559A1 Biaryl-methanethio-, -sulphinyl- and sulphonyl derivatives
10/19/2005EP1585757A2 Peptide deformylase inhibitors
10/19/2005EP1585731A2 Histamine h3 receptor antagonists, preparaton and therapeutic uses
10/19/2005EP1585511A2 Asthma and allergic inflammation modulators
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005EP1337523B1 2,4-substituted pyridine derivatives
10/19/2005CN1684944A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/19/2005CN1683339A 7-substituted-8-methoxy fluoroquinolone carboxylic derivatives, preparing process, preparation and use thereof
10/19/2005CN1683338A Process for preparing N-methyl quinoline codide compounds by ester reaction solvent
10/19/2005CN1682702A Method for preparing medicine composition capable of inhibiting post infective virus proteinase
10/13/2005WO2005095409A2 Tetrahydroquinoline derivatives and a process for preparing the same
10/13/2005WO2005095346A1 3-((hetero)arylsulfonyl)-8-` (aminoalkyl)oxy!quinolines as 5-ht6 receptor antagonists for the treatment of cns disorders
10/13/2005WO2005095338A1 Alkoxyphenylpropanoic acid derivatives
10/13/2005WO2005095334A1 Sulfonamide compounds for the treatment of neurodegenerative disorders
10/13/2005WO2005095327A1 Aniline derivatives
10/13/2005WO2005095326A2 2-amino- and 2-thio-substituted 1,3-diaminopropanes
1 ... 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 ... 277